Oncogene - Table of Contents alert Volume 32 Issue 37

TABLE OF CONTENTS Volume 32, Issue 37 (September 2013) In this issue Review Original Articles Letter to the Editor Response to Letter to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Molecular Systems Biology Top Downloads 2013*  Programming biological models in Python using PySB  Construction of human activity-based phosphorylation networks Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers  Shared control of gene expression in bacteria by transcription factors and global physiology of the cell  *Jan - July Review Top The mutant p53 mouse as a pre-clinical model J G Jackson and G Lozano Oncogene 2013 32: 4325-4330; advance online publication, January 14, 2013; 10.1038/onc.2012.610 Abstract | Full Text Original Articles Top Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia E Lainey, A Wolfromm, N Marie, D Enot, M Scoazec, C Bouteloup, C Leroy, J-B Micol, S De Botton, L Galluzzi, P Fenaux and G Kroemer Oncogene 2013 32: 4331-4342; advance online publication, October 22, 2012; 10.1038/onc.2012.469 Abstract | Full Text Mesenchymal stem cells promote growth and angiogenesis of tumors in mice W-H Huang, M-C Chang, K-S Tsai, M-C Hung, H-L Chen and S-C Hung Oncogene 2013 32: 4343-4354; advance online publication, October 22, 2012; 10.1038/onc.2012.458 Abstract | Full Text Efficient TGFβ-induced epithelial–mesenchymal transition depends on hyaluronan synthase HAS2 OPEN H Porsch, B Bernert, M Mehić, A D Theocharis, C-H Heldin and P Heldin Oncogene 2013 32: 4355-4365; advance online publication, October 29, 2012; 10.1038/onc.2012.475 Abstract | Full Text Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells J J Martino, B A Wall, E Mastrantoni, B J Wilimczyk, S N La Cava, K Degenhardt, E White and S Chen Oncogene 2013 32: 4366-4376; advance online publication, October 22, 2012; 10.1038/onc.2012.471 Abstract | Full Text The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression C L Doçi, G Zhou and M W Lingen Oncogene 2013 32: 4377-4386; advance online publication, October 22, 2012; 10.1038/onc.2012.464 Abstract | Full Text ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression F Fallone, S Britton, L Nieto, B Salles and C Muller Oncogene 2013 32: 4387-4396; advance online publication, October 22, 2012; 10.1038/onc.2012.462 Abstract | Full Text NANOG modulates stemness in human colorectal cancer J Zhang, L A Espinoza, R J Kinders, S M Lawrence, T D Pfister, M Zhou, T D Veenstra, S S Thorgeirsson and J M Jessup Oncogene 2013 32: 4397-4405; advance online publication, October 22, 2012; 10.1038/onc.2012.461 Abstract | Full Text A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo C Eberlein, J Kendrew, K McDaid, A Alfred, J S Kang, V N Jacobs, S J Ross, C Rooney, N R Smith, J Rinkenberger, A Cao, A Churchman, J F Marshall, H M Weir, V Bedian, D C Blakey, I N Foltz and S T Barry Oncogene 2013 32: 4406-4416; advance online publication, October 29, 2012; 10.1038/onc.2012.460 Abstract | Full Text Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110α/PIK3CA but not by HER2 or mutant AKT1 F M Berglund, N R Weerasinghe, L Davidson, J C Lim, B J Eickholt and N R Leslie Oncogene 2013 32: 4417-4426; advance online publication, October 22, 2012; 10.1038/onc.2012.459 Abstract | Full Text Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations T Yamada, S Takeuchi, N Fujita, A Nakamura, W Wang, Q Li, M Oda, T Mitsudomi, Y Yatabe, Y Sekido, J Yoshida, M Higashiyama, M Noguchi, H Uehara, Y Nishioka, S Sone and S Yano Oncogene 2013 32: 4427-4435; advance online publication, October 8, 2012; 10.1038/onc.2012.446 Abstract | Full Text Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway Y-L Hsu, M-F Hou, P-L Kuo, Y-F Huang and E-M Tsai Oncogene 2013 32: 4436-4447; advance online publication, October 8, 2012; 10.1038/onc.2012.444 Abstract | Full Text NBN Phosphorylation regulates the accumulation of MRN and ATM at sites of DNA double-strand breaks J Wen, K Cerosaletti, K J Schultz, J A Wright and P Concannon Oncogene 2013 32: 4448-4456; advance online publication, November 12, 2012; 10.1038/onc.2012.443 Abstract | Full Text Letter to the Editor Top Renal disease as a potential compounding factor in carcinogenesis experiments with Cd151-null mice L K Ashman Oncogene 2013 32: 4457; advance online publication, March 11, 2013; 10.1038/onc.2013.73 Full Text Response to Letter to the Editor Top Renal disease appears not to affect carcinogenesis in CD151-null mice M E Hemler, J Hoff, Q Li and X H Yang Oncogene 2013 32: 4458; advance online publication, March 18, 2013; 10.1038/onc.2013.79 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.